ArticleMolecular therapy. Advances2026

Case study of resecabtagene autoleucel in a subject with diffuse cutaneous systemic sclerosis treated in the RESET-SSc trial.

Daniel Nunez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.